Windsor Creek Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,672
Closed -$316K 198
2019
Q2
$316K Sell
5,672
-7,794
-58% -$1.08M 0.09% 133
2019
Q1
$1.97M Sell
13,466
-2,680
-17% -$389K 0.53% 42
2018
Q4
$2.2M Buy
+16,146
New +$2.65M 0.7% 34

Other funds holding AGN

Windsor Creek Advisors's AGN Position: Q3 2019 in Review

Windsor Creek Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 5,672 shares — an estimated $316K sold.

Windsor Creek Advisors first reported a position in AGN in Q4 2018 and held it in 3 quarters. The position peaked at $2.2M in Q4 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Windsor Creek Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Windsor Creek Advisors sold 5,672 Allergan plc shares in Q3 2019, an estimated $316K.
  • Windsor Creek Advisors first reported a position in Allergan plc in Q4 2018 and held it in 3 quarters.
  • Windsor Creek Advisors's Allergan plc position peaked at $2.2M in Q4 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Windsor Creek Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.